相关实验视频
Updated: May 28, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
骨髓瘤中NF-κB信号传递和瘤微环境:对免疫逃避和治疗耐药性的影响
Shaoyan Shi1, Xuehai Ou1, Chao Liu1
1Department of Hand Surgery, Honghui Hospital, Xi'an Jiaotong University, XI'an, China.
核因子-kappa B (NF-κB) 驱动骨髓瘤免疫逃避和治疗抵抗. 抑制NF-κB可能会改善这种侵袭性癌症的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 骨髓瘤是一种具有不良预后的侵袭性骨癌.
- 瘤细胞逃避免疫反应并抵抗治疗.
- 核转录因子NF-κB通路调节免疫反应和瘤微环境.
研究的目的:
- 研究NF-κB在骨髓瘤免疫抑制中的作用.
- 探索NF-κB对免疫细胞招募和两极分化的影响.
- 了解NF-κB对免疫检查点分子表达和治疗耐药性的影响.
主要方法:
- 对NF-κB信号在骨髓瘤发展中的分析.
- 检查NF-κB对瘤相关的巨细胞和髓状细胞衍生的抑制细胞的影响.
- 评估NF-κB在免疫监测逃避和治疗耐药性方面的作用.
主要成果:
- 通过影响免疫细胞两极化,NF-κB促进免疫抑制.
- NF-κB上调调节像PD-L1这样的免疫检查点分子,帮助免疫逃避.
- 通过抗亡途径,NF-κB增强了瘤细胞对化疗和放射治疗的抵抗力.
结论:
- NF-κB是骨髓瘤进展和治疗失败的关键驱动因素.
- 针对NF-κB,可能使用免疫检查点抑制剂,提供了一个有前途的治疗策略.
- 对NF-κB抑制的进一步研究可能会导致骨髓瘤治疗和患者预后的改善.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
相关概念视频
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Mitogens and the Cell Cycle
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...